CRISPR Therapeutics News

CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 15 16:29 ET

CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 22 16:03 ET

CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 15 16:51 ET

CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 15 16:34 ET

CRISPR Therapeutics | 424B5: Prospectus

Feb 13 08:49 ET

CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 29 16:14 ET

CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 16 00:00 ET

CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

May 30, 2023 16:38 ET

CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

May 10, 2023 15:23 ET

CRISPR Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 25, 2023 16:28 ET

CRISPR Therapeutics | 424B5: Prospectus

Jan 15, 2021 16:10 ET

CRISPR Therapeutics | 424B5: Prospectus

Dec 11, 2020 08:12 ET

CRISPR Therapeutics | 424B5: Prospectus

Jul 1, 2020 17:12 ET

CRISPR Therapeutics | 424B5: Prospectus

Jun 29, 2020 16:24 ET

CRISPR Therapeutics | 424B5: Prospectus

Nov 21, 2019 16:12 ET

CRISPR Therapeutics | 424B5: Prospectus

Nov 19, 2019 16:27 ET

CRISPR Therapeutics | 424B5: Prospectus

Aug 30, 2019 16:08 ET

CRISPR Therapeutics | 424B5: Prospectus

Nov 8, 2018 17:57 ET

CRISPR Therapeutics | 424B5: Prospectus

Sep 24, 2018 20:23 ET

CRISPR Therapeutics | 424B5: Prospectus

Sep 21, 2018 16:10 ET